Business Wire

KnowBe4 Finds U.S. Phishing Emails Focus on Password Alerts and Policy Changes While EMEA Focuses on Everyday Tasks

Share

KnowBe4, the provider of the world’s largest security awareness training and simulated phishing platform, today announced the results of its Q4 2021 top-clicked phishing report.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220119005245/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

KnowBe4 Q4 2021 Top-Clicked Phishing Report Infographic (Graphic: Business Wire)

“When comparing the results from the U.S. phishing emails to those in Europe, the Middle East and Africa (EMEA), email subjects in the U.S. appear to originate from the users’ organizations and are focused on security alerts related to passwords and internal company policy changes,” said Stu Sjouwerman, CEO, KnowBe4. “However, in EMEA, the top subjects are related to users’ everyday tasks and the subject lines appear to be more personalized to entice the user to click. As expected, we did see some phishing email subjects related to the holidays, especially holiday shopping in particular. Employees should remain ever vigilant when it comes to suspicious email messages in their inboxes because just one wrong click can wreak havoc for an organization.”

Top 10 Email Categories Globally:

  1. Business
  2. Online Services
  3. Human Resources
  4. IT
  5. Banking and Finance
  6. Coronavirus/COVID-19 Phishing
  7. Mail Notifications
  8. Holiday
  9. Phishing for Sensitive Information
  10. Social Networking

Top phishing email subjects were also broken out, comparing those in the U.S. to those in EMEA. In Q4 2021, KnowBe4 examined tens of thousands of email subject lines from simulated phishing tests. The organization also reviewed ‘in-the-wild’ email subject lines that show actual emails users received and reported to their IT departments as suspicious. The results are below.

Top Phishing Email Subjects:

The U.S.

  1. Password Check Required Immediately
  2. Important: Dress Code Changes
  3. Vacation Policy Update
  4. Important Social Media Policy Change
  5. Employee Discounts on Amazon for your Holiday Shopping

EMEA

  1. Accept Invitation - Staff Meeting via Teams
  2. Employee Portal - Timecard Not Submitted
  3. Enclosed attachment for your review
  4. Immediate password verification required
  5. [[company_name]] Invoice

*Capitalization and spelling are as they were in the phishing test subject line.
**Email subject lines are a combination of both simulated phishing templates created by KnowBe4 for clients, and custom tests designed by KnowBe4 customers.

Common “In-the-Wild” attacks:

  • IT: Cloud Enrollment
  • Special Project Information
  • You Have Some New Messages
  • Teams Events
  • Microsoft: Private Shared Document Received

*Capitalization and spelling are as they were in the phishing test subject line.
**In-the-wild email subject lines represent actual emails users received and reported to their IT departments as suspicious. They are not simulated phishing test emails.

For more information on KnowBe4, visit www.knowbe4.com.

About KnowBe4

KnowBe4, the provider of the world’s largest security awareness training and simulated phishing platform, is used by more than 44,000 organizations around the globe. Founded by IT and data security specialist, Stu Sjouwerman, KnowBe4 helps organizations address the human element of security by raising awareness about ransomware, CEO fraud, and other social engineering tactics through a new-school approach to awareness training on security. Kevin Mitnick, an internationally recognized cybersecurity specialist and KnowBe4's Chief Hacking Officer, helped design the KnowBe4 training based on his well-documented social engineering tactics. Tens of thousands of organizations rely on KnowBe4 to mobilize their end users as their last line of defense.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Amanda Tarantino
amandat@knowbe4.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 02:09:00 CEST | Press release

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines,today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio har

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 22:06:00 CEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye